Range
30.74 - 31.74
Vol / Avg.
39K/84.9K
Div / Yield
-
52 Wk
28.4 - 54
Mkt Cap
533.1M
Payout Ratio
-
Open
31.61
P/E
-
EPS
-1.29
Shares
16.8M
Outstanding
16.8M
Total Float
16.3M
Sector: Health Care.Industry: Pharmaceuticals
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-1.390-1.340 0.0500
REV0
Q4 2020Est.ActualSurprise
EPS-1.160-1.280 -0.1200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RLMDRelmada Therapeutics-0.38%533.1M

Relmada Therapeutics Frequently Asked Questions

Q

How do I buy Relmada Therapeutics (RLMD) stock?

A

You can purchase shares of Relmada Therapeutics (NASDAQ: RLMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Relmada Therapeutics's (RLMD) competitors?

Q

What is the target price for Relmada Therapeutics (RLMD) stock?

A

The latest price target for Relmada Therapeutics (NASDAQ: RLMD) was reported by Goldman Sachs on October 28, 2020. The analyst firm set a price target for 40.00 expecting RLMD to rise to within 12 months (a possible 26.02% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Relmada Therapeutics (RLMD)?

A

The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $31.74 last updated Today at 4:04:16 PM.

Q

Does Relmada Therapeutics (RLMD) pay a dividend?

A

There are no upcoming dividends for Relmada Therapeutics.

Q

When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?

A
Relmada Therapeutics’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is Relmada Therapeutics (RLMD) going to split?

A

There is no upcoming split for Relmada Therapeutics.

Q

What sector and industry does Relmada Therapeutics (RLMD) operate in?

A

Relmada Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.